These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 35835313)
1. PHLPPs: Emerging players in metabolic disorders. Balamurugan K; Chandra K; Sai Latha S; Swathi M; Joshi MB; Misra P; Parsa KVL Drug Discov Today; 2022 Oct; 27(10):103317. PubMed ID: 35835313 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. Lupse B; Annamalai K; Ibrahim H; Kaur S; Geravandi S; Sarma B; Pal A; Awal S; Joshi A; Rafizadeh S; Madduri MK; Khazaei M; Liu H; Yuan T; He W; Gorrepati KDD; Azizi Z; Qi Q; Ye K; Oberholzer J; Maedler K; Ardestani A Cell Rep; 2021 Aug; 36(5):109490. PubMed ID: 34348155 [TBL] [Abstract][Full Text] [Related]
3. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms. Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608 [TBL] [Abstract][Full Text] [Related]
4. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy. Zhang M; Wang X; Liu M; Liu D; Pan J; Tian J; Jin T; Xu Y; An F J Cell Mol Med; 2020 Apr; 24(8):4612-4623. PubMed ID: 32150791 [TBL] [Abstract][Full Text] [Related]
6. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice. Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606 [TBL] [Abstract][Full Text] [Related]
7. Emerging roles of PHLPP phosphatases in metabolism. Cha JH; Jeong Y; Oh AR; Lee SB; Hong SS; Kim K BMB Rep; 2021 Sep; 54(9):451-457. PubMed ID: 34353431 [TBL] [Abstract][Full Text] [Related]
8. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble. Sharma M; Dey CS Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971 [TBL] [Abstract][Full Text] [Related]
9. [Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway]. Cai G; Zhang J; Wang R Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):8-15. PubMed ID: 33441223 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma. Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736 [TBL] [Abstract][Full Text] [Related]
11. Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. Qiao M; Wang Y; Xu X; Lu J; Dong Y; Tao W; Stein J; Stein GS; Iglehart JD; Shi Q; Pardee AB Mol Cell; 2010 May; 38(4):512-23. PubMed ID: 20513427 [TBL] [Abstract][Full Text] [Related]
12. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637 [TBL] [Abstract][Full Text] [Related]
13. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620 [TBL] [Abstract][Full Text] [Related]
14. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death. Saxena S; Shukla S; Kakkar P Toxicol Appl Pharmacol; 2018 May; 347():92-103. PubMed ID: 29626488 [TBL] [Abstract][Full Text] [Related]
15. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart. Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369 [TBL] [Abstract][Full Text] [Related]
16. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes. Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368 [TBL] [Abstract][Full Text] [Related]
18. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer. Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623 [TBL] [Abstract][Full Text] [Related]